Pennsylvania Jury Awards $1.75M In Risperdal Gynecomastia Case
PHILADELPHIA — A Pennsylvania state court jury on Nov. 9 awarded $1.75 million to a man who said his use of the atypical antipsychotic drug Risperdal from as young as 4...To view the full article, register now.
Already a subscriber? Click here to view full article